Comments
Commented by Carsten Mainitz on February 11th, 2022 | 11:01 CET
Deutsche Bank, Hong Lai Huat, Heidelberger Druck - Things are stabilizing!
After a sharp correction, the stabilization of the stock markets - due to concerns about faster than expected interest rate increases - has been successful. The DAX was able, at least temporarily, to fend off a fall below the psychologically important 15,000 point mark. The German benchmark index is driven by banks and financial stocks, which have outperformed for weeks. There are also outliers from the second row, which could surprise positively due to the presented figures.
Read
Commented by Nico Popp on February 11th, 2022 | 10:48 CET
Lufthansa, Kleos Space, Meta: The sky is NOT the limit
Keep going, always keep going! What once drove Oliver Kahn to peak performance is also the motto of enterprising companies. Companies that make their products a little better every day or open up entirely new markets are not likely to be outdone by the competition any time soon. We look at three companies doing something special in their own way.
Read
Commented by Juliane Zielonka on February 10th, 2022 | 13:44 CET
Plug Power, CoinSmart, Lufthansa - Growth through ongoing onboard additions
Plug Power continues to expand its market leadership in the hydrogen fuel cell segment and brings reinforcements to expand its international business. Crypto platform CoinSmart posts 52% trading growth and will face interested investors in live zoom call. While Lufthansa gets into trouble with the antitrust office, Italy's ITA Airlines signals interest in a strategic partnership.
Read
Commented by Carsten Mainitz on February 10th, 2022 | 13:40 CET
Alerio Gold, Aixtron, Siltronic - The signs point to growth!
The US Federal Reserve (Fed) has for some time begun to scale back bond purchases massively and will raise the key interest rate at its next meeting in March. Semiconductor manufacturers have indicated that the chip shortage will level off over the course of the year. How will these developments affect commodity prices and cryptocurrencies?
Read
Commented by Stefan Feulner on February 10th, 2022 | 12:34 CET
Standard Lithium, Yorkton Ventures, Deutsche Bank - The new favorites
For many years, shares of banks and financial service providers underperformed the overall market. With the end of the ultra-loose monetary policy of the central banks and several possible interest rate hikes due to continued high inflation, stocks are benefiting disproportionately and sometimes break through their downward trends that have prevailed for years. In addition to high energy costs, the blame for the enormous price increases lies with the further rise in raw material prices. Because of the demand side due to the energy transition, lithium, in particular, is rushing from high to high.
Read
Commented by Nico Popp on February 10th, 2022 | 11:14 CET
BioNTech, Cardiol Therapeutics, Peloton: Future check on pandemic stocks
There are pandemic stocks that are already out today. But there are also pandemic stocks that are only now taking off operationally. We take a look at three stocks and do a future check: Where has the pandemic only provided the initial spark, and where is the hype irretrievably over?
Read
Commented by André Will-Laudien on February 10th, 2022 | 10:32 CET
The 100% interest winners: Allianz, Commerzbank, Deutsche Bank, MAS Gold - The precious metals are coming!
For a long time, the Bund Future had been able to hold well above 170. The 10-year Bund contract even reached prices above 178 points at its peak. Since mid-December 2021, however, the tide has turned. The German 10-year yield literally exploded from -0.30 to +0.27%. Some observers will say, "Nothing much has happened!" Wrong - the time of negative yields is history. Long-term mortgage rates also rose by a full 70 basis points during the same period. This marks the end of the phase of ultra-low interest rates, and it also puts real estate financing in an entirely new light. And the accompanying high inflation has many investors looking to precious metals - they are seen as a hedge against inflation. Which stocks are winning in this environment?
Read
Commented by Carsten Mainitz on February 9th, 2022 | 14:12 CET
Nel ASA, First Hydrogen, Nordex - Hydrogen with tailwind, storm at Nordex!
Germany's path to climate neutrality is mapped out in the Climate Protection Act. With a tightening, the goal of greenhouse gas neutrality by 2045 is currently being targeted. This goal is to be achieved with the help of renewable energies such as wind power and photovoltaics. The transport sector poses a particular challenge. Here, CO2 emissions have risen over the past two decades despite the development of more efficient vehicles. While batteries are likely to prevail in passenger cars, hydrogen and fuel cell technology is considered the favorite in transportation due to higher ranges and shorter refueling times.
Read
Commented by Armin Schulz on February 9th, 2022 | 13:42 CET
Infineon, BrainChip, AMD - Chip industry holds enormous potential
The chip industry is not even close to keeping up with production, which will remain the case in 2022. Overall, the industry's revenues increased by about 25%, partly due to manufacturers' price increases. To meet demand, companies are investing in their production facilities. Micron plans to invest USD 150 billion, Intel USD 20 billion. Due to the new developments in electric vehicles, artificial intelligence, cloud computing and the continuously growing data centers, demand will also likely increase further in the coming years. We, therefore, take a look at three chipmakers.
Read
Commented by André Will-Laudien on February 9th, 2022 | 12:22 CET
MorphoSys, Defence Therapeutics, Valneva, CureVac - Find the bio blockbuster!
The biotech sector is a highly dynamic growth market within the equity universe. It is characterized by investment volumes of unprecedented size, which is also the reason for the high innovation rate characteristic of the sector. Price reactions to positive or negative surprises can be very volatile, and these tendencies are often exacerbated by the intervention of stop orders or the occurrence of derivative slippage. Vaccine manufacturers were down over 50% across the board, as the pandemic is being traded as a phase-out. The vaccination rate does not appear to be increasing significantly. Where are the opportunities for investors at the moment?
Read